Sanofi’s multiple sclerosis hopeful tolebrutinib faced dual setbacks on Monday, with a late-stage failure in one form of the ...

Fly this December and receive exclusive wildlife-themed amenity kits, highlighting endangered species with eco-friendly ...

Coming up in the back half of December, the FDA will issue a verdict on Vanda Pharmaceuticals’ gastroparesis drug tradipitant ...

Hyderabad: Telangana Rising Global Summit made history as 3,000 drones formed the world’s longest airborne sentence. The new ...

The cells of all animals—including humans—are characterized by their ability to adhere particularly well to surfaces in their ...

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, ...

Weyerhaeuser (WY) and Aymium signed a memorandum of understanding to produce and sell 1.5M tons of sustainable biocarbon ...

Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that its Board of Directors has appointed Mario Alberto Accardi PhD, President and founder of ...

Formation Bio is inking a deal worth more than $600 million in biobucks for ex-China rights to a next-gen immunology asset ...

Sanofi says it has reached an agreement with Dren Bio that would see it take control of autoimmune disease treatment DR-0201, a bispecific antibody-based myeloid cell engager with the potential to ...

Form I‑140G, the Immigrant Petition for the Gold Card Program, can be submitted through the new Trumpcard.gov website, which ...

Bennu samples reveal biological sugars, a strange, gum-like material, and ancient stardust that shed light on the early solar ...